Literature DB >> 3634775

Studies on the antibacterial activity of dodecylglycerol. Its limited metabolism and inhibition of glycerolipid and lipoteichoic acid biosynthesis in Streptococcus mutans BHT.

J L Brissette, E A Cabacungan, R A Pieringer.   

Abstract

Growth-inhibitory concentrations of racemic sn-1(3)-dodecylglycerol inhibit the incorporation of [14C] glycerol into lipids and lipoteichoic acid of Streptococcus mutans BHT and alter the per cent composition of the glycerolipids. Increases in phosphatidic acid and diphosphatidylglycerol (at the expense of phosphatidylglycerol) contribute the most to the change in lipid composition. No cellular lysis occurs under these conditions. Radioactive racemic sn-1(3)-dodecylglycerol is readily taken up by the cell and is metabolized primarily to lysophosphatidic acid and phosphatidic acid with smaller amounts converted to phosphatidylglycerol and diacylglycerol. The accumulation of phosphatidic acid and the loss of viability respond in parallel to different concentrations of dodecylglycerol. An increase in CTP is also observed which together with the increase in phosphatidic acid suggests a possible impairment in the synthesis of CDP-diacylglycerol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3634775

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.

Authors:  Kouichirou Shin; Ken Yaegaki; Takatoshi Murata; Hisataka Ii; Tomoko Tanaka; Izumi Aoyama; Koji Yamauchi; Tomohiro Toida; Keiji Iwatsuki
Journal:  Clin Oral Investig       Date:  2010-05-29       Impact factor: 3.573

2.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

4.  In vitro antimicrobial activities of bakuchiol against oral microorganisms.

Authors:  H Katsura; R I Tsukiyama; A Suzuki; M Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 5.  An update on the therapeutic role of alkylglycerols.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Mar Drugs       Date:  2010-08-05       Impact factor: 5.118

6.  Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers.

Authors:  M P Haynes; H R Buckley; M L Higgins; R A Pieringer
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  The relative proportions of different lipid classes and their fatty acid compositions change with culture age in the cariogenic dental pathogen Streptococcus mutans UA159.

Authors:  Jenny E Custer; Bryan D Goddard; Stephen F Matter; Edna S Kaneshiro
Journal:  Lipids       Date:  2014-04-20       Impact factor: 1.880

8.  Squalamine: an aminosterol antibiotic from the shark.

Authors:  K S Moore; S Wehrli; H Roder; M Rogers; J N Forrest; D McCrimmon; M Zasloff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  A thioesterase bypasses the requirement for exogenous fatty acids in the plsX deletion of Streptococcus pneumoniae.

Authors:  Joshua B Parsons; Matthew W Frank; Marc J Eleveld; Joost Schalkwijk; Tyler C Broussard; Marien I de Jonge; Charles O Rock
Journal:  Mol Microbiol       Date:  2015-01-30       Impact factor: 3.501

10.  Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo.

Authors:  Ying-Chi Lin; Patrick M Schlievert; Michele J Anderson; Christina L Fair; Matthew M Schaefers; Ramaiah Muthyala; Marnie L Peterson
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.